Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 05, 2018 08:00 ET | Source: NeuroRx, Inc.

NeuroRx to Present at the Annual Rodman & Renshaw Global Investment Conference on Sept 5, 2018

WILMINGTON, Del., Sept. 05, 2018 (GLOBE NEWSWIRE) -- NeuroRx, a clinical stage biopharma company developing NRX-101, the first oral therapy for Severe Bipolar Depression with Acute Suicidal Ideation...
September 04, 2018 09:10 ET | Source: NeuroRx, Inc.

NeuroRx Announces Phase 2 Data from NRX-101, Initiates Pivotal Study for Severe Bipolar Depression with Acute Suicidal Ideation & Behavior (ASIB)

WILMINGTON, De. , Sept. 04, 2018 (GLOBE NEWSWIRE) -- NeuroRx, a clinical stage biopharma company developing NRX-101, the first oral therapy for Severe Bipolar Depression with Acute Suicidal Ideation...
May 07, 2018 07:00 ET | Source: NeuroRx, Inc.

NeuroRx Receives Special Protocol Agreement (SPA) and Biomarker Letter of Support from FDA for Pivotal Studies of NRX-101 to treat Severe Bipolar Depression in Patients with Acute Suicidal Ideation & Behavior

WILMINGTON, Del., May 07, 2018 (GLOBE NEWSWIRE) -- NeuroRx, a clinical stage biopharmaceutical company developing the first drug regimen to treat Severe Bipolar Depression in patients with Acute...